Amyotrophic lateral sclerosis with spinocerebellar ataxia (Q86921): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Expansões intermediárias da repetição CAG na ataxina 2 (ATXN2) foram identificadas como um fator de risco genético para o desenvolvimento de ELA esporádica. Expansões completas de ATXN2 estão associadas à ataxia espinocerebelar tipo 2 (SCA2). Além disso, um único relatório documentou a coocorrência de SCA2 e ELA em membros separados de uma família, ambos com expansões ATXN2 completas.
description / endescription / en
 
Intermediate expansions of the CAG repeat in Ataxin 2 (ATXN2) have been identified as a genetic risk factor for the development of sporadic ALS. Full expansions of ATXN2 are associated with spinocerebellar ataxia type 2 (SCA2). In addition, a single report has documented the co-occurrence of SCA2 and ALS in separate members of a family, both carrying full ATXN2 expansions.

Revision as of 12:29, 15 August 2026

Intermediate expansions of the CAG repeat in Ataxin 2 (ATXN2) have been identified as a genetic risk factor for the development of sporadic ALS. Full expansions of ATXN2 are associated with spinocerebellar ataxia type 2 (SCA2). In addition, a single report has documented the co-occurrence of SCA2 and ALS in separate members of a family, both carrying full ATXN2 expansions.
Language Label Description Also known as
default for all languages
ID_84805458
    English
    Amyotrophic lateral sclerosis with spinocerebellar ataxia
    Intermediate expansions of the CAG repeat in Ataxin 2 (ATXN2) have been identified as a genetic risk factor for the development of sporadic ALS. Full expansions of ATXN2 are associated with spinocerebellar ataxia type 2 (SCA2). In addition, a single report has documented the co-occurrence of SCA2 and ALS in separate members of a family, both carrying full ATXN2 expansions.

      Statements